HEALTHY INDIVIDUALS RESEARCH STUDY
HPP737 is an investigational drug that may be used to treat COPD in the future. This study is designed to examine how safe the drug is, how well the body is able to tolerate the drug, and how much of the drug gets in your blood stream.
Length of Study:
All eligible subjects must be able to come to our research center for: a Screening Visit to determine your eligibility. There is One Inpatient stay of at least 18 days and 17 nights, and a Follow-up Visit 7-10 days following the last dose of the study medication. Participation in the study will last approximately 26 days from admission for the inpatient stay until the final follow-up visit.
- Individuals in good general health
- 18 – 55 years of age
Qualified participants may receive up to $3,250.